Ritu Baral
Stock Analyst at TD Cowen
(4.99)
# 40
Out of 4,707 analysts
1058
Total ratings
58.4%
Success rate
47.9%
Average return
Main Sectors:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics | Maintained: Buy | $78 | $35.28 | +121.09% | 27 | Aug 31, 2026 | |
| OVID Ovid Therapeutics | Maintained: Buy | n/a | $2.75 | - | 25 | Aug 13, 2026 | |
| MIST Milestone Pharmaceuticals | Maintained: Buy | $8 | $1.13 | +611.11% | 36 | Aug 12, 2026 | |
| NGNE Neurogene | Maintained: Buy | n/a | $38.13 | - | 24 | Aug 11, 2026 | |
| VTVT vTv Therapeutics | Maintained: Buy | $67 | $32.79 | +104.33% | 4 | Aug 7, 2026 | |
| INSM Insmed | Maintained: Buy | $243 | $124.89 | +94.57% | 73 | Aug 6, 2026 | |
| IRD Opus Genetics | Maintained: Buy | n/a | $4.34 | - | 2 | Aug 6, 2026 | |
| SRPT Sarepta Therapeutics | Rated: Hold | $17 | $20.94 | -18.82% | 104 | Aug 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $510 | $352.48 | +44.69% | 28 | Aug 6, 2026 | |
| GHRS GH Research | Maintained: Buy | n/a | $27.79 | - | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 | $27.58 | +34.16% | 66 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $14.04 | +106.55% | 23 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $267 | $152.28 | +75.33% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $403 | $351.26 | +14.73% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $482 | $260.10 | +85.31% | 101 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.67 | +114.13% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $644 | $534.16 | +20.56% | 45 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.28 | - | 21 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.30 | - | 9 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $21.60 | +112.96% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €8.60 | €4.03 | +113.62% | 8 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.73 | - | 5 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $35.81 | - | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $10.71 | +96.08% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $12.39 | -35.43% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.19 | - | 25 | Nov 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.61 | - | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.1609 | n/a | 37 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.6634 | n/a | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.98 | n/a | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.14 | n/a | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $59.09 | n/a | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $30.40 | n/a | 11 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $56.71 | n/a | 9 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.46 | n/a | 22 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $57.42 | n/a | 5 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $68.81 | n/a | 37 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.88 | n/a | 8 | Jan 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $45.68 | n/a | 17 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 23 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.51 | n/a | 4 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $75.35 | n/a | 22 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.54 | n/a | 14 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $23.17 | n/a | 7 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.56 | n/a | 7 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.53 | n/a | 6 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $29 | $1.94 | n/a | 2 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $291 → $355 | $212.50 | n/a | 5 | Jan 27, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $1.6 | $14.25 | n/a | 17 | Nov 18, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $3 | $0.0001 | n/a | 7 | Jul 9, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $2.65 | n/a | 5 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.19 | n/a | 3 | Jun 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $19.12 | n/a | 1 | Mar 14, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $8.06 | n/a | 1 | Feb 21, 2012 |
Vera Therapeutics
Aug 31, 2026
Maintained: Buy
Price Target: $78
Current: $35.28
Upside: +121.09%
Ovid Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: n/a
Current: $2.75
Upside: -
Milestone Pharmaceuticals
Aug 12, 2026
Maintained: Buy
Price Target: $8
Current: $1.13
Upside: +611.11%
Neurogene
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $38.13
Upside: -
vTv Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $67
Current: $32.79
Upside: +104.33%
Insmed
Aug 6, 2026
Maintained: Buy
Price Target: $243
Current: $124.89
Upside: +94.57%
Opus Genetics
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $4.34
Upside: -
Sarepta Therapeutics
Aug 6, 2026
Rated: Hold
Price Target: $17
Current: $20.94
Upside: -18.82%
Praxis Precision Medicines
Aug 6, 2026
Maintained: Buy
Price Target: $510
Current: $352.48
Upside: +44.69%
GH Research
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $27.79
Upside: -
Aug 5, 2026
Rated: Buy
Price Target: $37
Current: $27.58
Upside: +34.16%
Aug 5, 2026
Maintained: Buy
Price Target: $29
Current: $14.04
Upside: +106.55%
Aug 4, 2026
Maintained: Buy
Price Target: $267
Current: $152.28
Upside: +75.33%
Aug 3, 2026
Maintained: Buy
Price Target: $403
Current: $351.26
Upside: +14.73%
Jul 31, 2026
Rated: Buy
Price Target: $482
Current: $260.10
Upside: +85.31%
Jul 31, 2026
Maintained: Buy
Price Target: $10
Current: $4.67
Upside: +114.13%
Jul 30, 2026
Maintained: Buy
Price Target: $644
Current: $534.16
Upside: +20.56%
Jul 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.28
Upside: -
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $7.30
Upside: -
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $21.60
Upside: +112.96%
Jun 8, 2026
Maintained: Buy
Price Target: €8.60
Current: €4.03
Upside: +113.62%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $12.73
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $35.81
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $21
Current: $10.71
Upside: +96.08%
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $12.39
Upside: -35.43%
Nov 16, 2025
Maintained: Hold
Price Target: n/a
Current: $1.19
Upside: -
Nov 10, 2025
Maintained: Buy
Price Target: n/a
Current: $16.61
Upside: -
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.1609
Upside: n/a
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.6634
Upside: n/a
Apr 11, 2025
Maintained: Hold
Price Target: n/a
Current: $5.98
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: n/a
Current: $1.14
Upside: n/a
Nov 23, 2021
Downgraded: Hold
Price Target: n/a
Current: $59.09
Upside: n/a
Mar 16, 2020
Maintained: Buy
Price Target: n/a
Current: $30.40
Upside: n/a
Feb 27, 2020
Maintained: Hold
Price Target: n/a
Current: $56.71
Upside: n/a
Feb 24, 2020
Maintained: Buy
Price Target: n/a
Current: $20.46
Upside: n/a
Aug 14, 2019
Rated: Buy
Price Target: n/a
Current: $57.42
Upside: n/a
May 8, 2019
Maintained: Hold
Price Target: n/a
Current: $68.81
Upside: n/a
Jan 6, 2019
Maintained: Buy
Price Target: n/a
Current: $14.88
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $45.68
Upside: n/a
Oct 12, 2018
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Jul 2, 2018
Downgraded: Hold
Price Target: n/a
Current: $3.51
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $75.35
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $1.54
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $23.17
Upside: n/a
Mar 16, 2017
Reiterated: Buy
Price Target: n/a
Current: $5.56
Upside: n/a
Dec 30, 2016
Rated: Hold
Price Target: n/a
Current: $5.53
Upside: n/a
May 15, 2014
Rated: Buy
Price Target: $25 → $29
Current: $1.94
Upside: n/a
Jan 27, 2014
Reiterated: Buy
Price Target: $291 → $355
Current: $212.50
Upside: n/a
Nov 18, 2013
Initiated Coverage: Hold
Price Target: $1.6
Current: $14.25
Upside: n/a
Jul 9, 2012
Reiterated: Buy
Price Target: $6 → $3
Current: $0.0001
Upside: n/a
Jun 25, 2012
Reiterated: Hold
Price Target: $8 → $6
Current: $2.65
Upside: n/a
Jun 18, 2012
Reiterated: Buy
Price Target: $6
Current: $1.19
Upside: n/a
Mar 14, 2012
Upgraded: Buy
Price Target: $13
Current: $19.12
Upside: n/a
Feb 21, 2012
Reiterated: Buy
Price Target: $14
Current: $8.06
Upside: n/a